|
Orthologous residues
|
|
ATP1A1 (human): Y10‑p, ATP1A1 iso2 (human): Y10‑p, ATP1A1 (mouse): Y10‑p, ATP1A1 (rat): Y10‑p
|
|
Characterization
|
|
Methods used to characterize site in vivo:
[32P] bio-synthetic labeling, mutation of modification site, phospho-antibody, phosphoamino acid analysis, western blotting
|
|
Relevant cell lines - cell types - tissues:
OK (renal)
|
|
Cellular systems studied:
cell lines
|
|
Species studied:
opossum
|
|
Upstream Regulation
|
|
Treatments, proteins and their effect on site modification:
|
|
Treatments
|
Referenced Treatments
|
Manipulated Protein
|
Referenced Protein
|
Effect
|
Notes
|
|
vanadate
|
|
|
|
increase
|
|
|
insulin
|
|
|
|
increase
|
|
|
genistein
|
insulin
|
|
|
inhibit treatment-induced increase
|
|
|
genistein
|
|
|
|
decrease
|
|
|
|
Downstream Regulation
|
|
Effect of modification (function):
activation
|
